CD44 receptor targeted nanoparticles augment immunity against tuberculosis in mice-Reference-Cited by-同舟云学术

CD44 receptor targeted nanoparticles augment immunity against tuberculosis in mice

Published:2022-09 Issue: Volume:349 Page:796-811
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Singh Vipul K.,Chau Eric,Mishra Abhishek,DeAnda Alexandro,Hegde Venkatesh L.,Sastry Jagannadha K.,Haviland David,Jagannath Chinnaswamy,Godin Biana,Khan Arshad

Funder

National Institute of Allergy and Infectious Diseases

Houston Methodist Research Institute

National Institutes of Health

Hunter Medical Research Institute

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference53 articles.

1. Global tuberculosis report 2020 – reflections on the global TB burden, treatment and prevention efforts;Chakaya;Int. J. Infect. Dis.,2021

2. Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis;Seung;Cold Spring Harb. Perspect Med.,2015

3. Tuberculosis comorbidity with communicable and noncommunicable diseases;Bates;Cold Spring Harb. Perspect Med.,2015

4. Host directed therapies for tuberculosis: futures strategies for an ancient disease;Palucci;Chemotherapy,2018

5. The immune response in tuberculosis;O’Garra;Annu. Rev. Immunol.,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomimetic nanoparticles with cell-membrane camouflage for rheumatoid arthritis;Matter;2024-03

2. Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus;Frontiers in Immunology;2024-01-08

3. Critical Review in Designing Plant-Based Anticancer Nanoparticles against Hepatocellular Carcinoma;Pharmaceutics;2023-05-29

4. Chronic Inflammation’s Transformation to Cancer: A Nanotherapeutic Paradigm;Molecules;2023-05-29

5. Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment;Bone Research;2023-02-27